Skip to content
OpenCapital
Get started

Evolus EOLS Free cash flow

Free cash flow at other companies

AbbVie logo
AbbVieABBV
$3.56B+155%

Other financials

Income statement

See full
Revenue$73.1M+6.7%
Gross profit$48.9M+4.8%
Operating income-$6.8M+54.9%
Net income-$10.7M+43.5%
EPS (diluted)-$0.16+46.7%

Balance sheet

See full
Cash & equivalents$49.8M-26.7%
Total debt$164.9M-4.1%
Total equity-$28.8M-336%
Total assets$220.6M+3.4%

Cash flow

See full
Operating cash flow-$10.0M+36.3%
CapEx$415.0K+30.1%

Valuation

See full
Market cap$470.86M-21.3%
Enterprise value$585.97M-16.6%
P/S1.6×-0.6×

Profitability

See full
Gross margin66.1%-2.4pp
Operating margin-13.7%-1.9pp
Net margin-14.4%-3.3pp
FCF margin-9.6%-3.6pp

Returns & leverage

See full
Return on equity-472.6%-1,534pp
Debt / equity22.2×—
Current ratio2×-0.3×

Where this comes from

Calculated from Evolus’s reported figures.

−$10.0Mnet cash from operating−$415.0Kcapital expenditures=-$10.37M

The official record: Evolus’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolus's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolus's free cash flow?
Evolus (EOLS) reported free cash flow of -$10.37M in Q1 2026.
How has Evolus's free cash flow changed year-over-year?
Evolus's free cash flow increased by 35.0% year-over-year, from -$15.95M to -$10.37M.
What is the long-term trend for Evolus's free cash flow?
Over 2 years (2021 to 2023), Evolus's free cash flow has grown at a 1.9% compound annual growth rate (CAGR), from -$33.78M to -$35.09M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.